A team of researchers has developed a new drug delivery system that was able to edit genes associated with high cholesterol and to partially restore vision in mice.

Scientists at Harvard and the Broad Institute have demonstrated that it is possible to treat sickle cell disease in mice using a new gene-editing technique.

Researchers prove they can engineer proteins to find new targets with high selectivity, a critical advance toward potential new treatments to help neuroregeneration, cytokine storm.

Wei Hsi “Ariel” Yeh dedicated her research in chemistry to solving some of the vast genetic mysteries behind hearing loss.